Immunoassay Systems - Global Strategic Business Report 2017 - Increasing Use of Immunoassays in Food Sciences and Quality Control - Research and Markets

News provided by

Research and Markets

26 Apr, 2017, 17:00 GMT

DUBLIN, April 26, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Immunoassay Systems - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Immunoassay Systems in US$ Thousand by the following Technology Segments:

  • Enzyme Immunoassay
  • Fluorescence Immunoassay
  • Chemiluminescence Immunoassay
  • Rapid Tests
  • ELISPOT
  • PCR
  • Others.

The report profiles 65 companies including many key and niche players such as:

  • Abbott Laboratories (USA)
  • Beckman Coulter, Inc. (USA)
  • bioMérieux SA (France)
  • Bio-Rad Laboratories Inc. (USA)
  • DiaSorin S.p.A (Italy)
  • Fujirebio, Inc. (Japan)
  • Ortho-Clinical Diagnostics, Inc. (USA)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (USA)
  • Sysmex Corporation (Japan)
  • Quidel Corporation (USA)
  • Tosoh Bioscience, Inc. (USA)

Key Topics Covered:

1. INDUSTRY OVERVIEW

  • Immunoassays
  • A Preface
  • Current and Future Analysis
  • Factors Sustaining Market Growth
  • Factors Restraining Growth
  • Developing Markets to Drive Sales
  • Radioimmunoassay Systems Lose Ground
  • Chemiluminescence Immunoassays Gain Demand
  • Expanding Immunoassay Applications Boost Demand

2. COMPETITIVE LANDSCAPE

3. MARKET TRENDS AND ISSUES

  • Bespoke Solutions Energize Market Growth
  • Multiplex Immunoassays Grow in Demand
  • Novel Biomarkers to Boost Market Growth
  • SERS
  • An Attractive Readout Strategy
  • Automated Immunoassay Systems
  • In Line with Automation Trend
  • Technological Advances to buoy ELISA's Prospects
  • Automation of ELISA
  • Enabling its Sustenance
  • Growing Popularity of Multiplexing Deters ELISA Market
  • Commoditization: A Key Issue Facing ELISA Product Manufacturers
  • Consolidation of Hospitals and Labs Drives Demand
  • POC and DIA Systems Grow in Demand
  • Prenatal Testing
  • An Opportunity Market
  • Rise in Infectious Diseases Raises Demand
  • Increasing Use of Immunoassays in Food Sciences and Quality Control
  • Growing Use in Environmental Testing

4. MACRO GROWTH DRIVERS AND APPLICATION MARKETS

  • Improving Healthcare Expenditure to Foster Growth
  • Blood Processing Market
  • Cancer Testing Markets
  • Drugs of Abuse Testing Market
  • Therapeutic Drug Monitoring
  • Immune Disease
  • Blood Grouping and Typing

5. CONCEPTUAL OVERVIEW

6. PRODUCT LAUNCHES/APPROVALS

  • Sekisui Diagnostics Launches new SEKURE® TPLA and RPR Assays for Syphilis Testing
  • Siemens Healthineers Introduces Atellica Solution automated Immunoassay Analyzer System
  • Abbott Introduces Alinity
  • Roche Introduces New Cobas e 801 Module
  • Siemens to Release Genetic Assay for Detection of Zika Virus
  • Fujirebio Europe Releases the Lumipulse G B - R - A - H - M - S PCT Assay
  • Fujirebio Releases "Lumipulse L 2400" CLIA System
  • Roche Introduces Elecsys® HTLV-I/II Immunoassay
  • Siemens Introduces ADVIA Centaur Syphilis Assay
  • Sysmex Introduces HISCL-800 Automated Immunoassay System
  • Siemens Introduces New Chemistry & Immunoassay Systems
  • Meso Scale Discovery Launches S-PLEX Assays
  • Modern Water Monitoring Introduces New Immunoassay Strip Test and Readers
  • Enzo Life Sciences Launches Amp'd ELISA Signal Amplification Kit
  • EMD Millipore Rolls Out New Immunoassay Kits
  • PerkinElmer Launches Novel Research Tools
  • Roche Releases Elecsys Syphilis Immunoassay

7. RECENT INDUSTRY ACTIVITY

  • Abbott Receives CE Mark for Alinity CI-Series Diagnostic Systems
  • Quidel Receives FDA Clearance for New Solana(R) Molecular Assay
  • Quidel Receives FDA Clearance for Solana(R) Strep Complete Assay
  • FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs
  • Beckman Coulter Receives FDA Clearance for Access TSH (3rd IS) Assay
  • Quidel Receives FDA Clearance for Solana(R) Influenza A+B Assay
  • Ortho Clinical Diagnostics Receives CE Mark Approval for VITROS® Immunodiagnostic HIV Combo Test
  • Siemens Healthcare Changes Name to Siemens Healthineers
  • DiaSorin to Acquire Focus Diagnostics' Molecular and Immunoassay Product Business
  • Quidel Receives CE Mark for Quidel's Sofia® S. pneumoniae Fluorescent Immunoassay
  • DiaSorin and Beckman Coulter Sign Agreement to Distribute Hepatitis and HIV Tests in China
  • bioMérieux Receives FDA 510(k) clearance for VIDAS® 3
  • Quidel Receives FDA Clearance for New Solana Molecular System and Solana Molecular Assay
  • Siemens Receives FDA Approval for Siemens HIV Combo assay
  • Eurofins Acquired ViraCor-IBT Laboratories
  • YSL Bio Signs Enters into Agreement with GeneX
  • Techne to Acquire CyVek
  • Gyros Enters into Distribution Agreement with Tekon Biotech
  • Singulex Partners with Tecan
  • OriGene Technologies Takes Over BioCheck
  • Techne Partners with Fisher Scientific

8. FOCUS ON SELECT MARKET PARTICIPANTS

9. GLOBAL MARKET PERSPECTIVE

For more information about this report visit http://www.researchandmarkets.com/research/rs4bzt/immunoassay

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716